Top Breakfast Beverage Slashes Common Cancer Risk
Recently, I told you that drinking coffee does more than just help you live healthier… it .
In that study, people who drank coffee in the morning had a whopping 31 percent reduced risk of dying from heart disease.
Wow!
Today, I have MORE good news about America’s favorite breakfast beverage. It turns out coffee could also reduce the risk of a type of cancer that impacts over 70,000 people in the U.S. every year…
Head and neck cancer (HNC) occurs in the lining of the mucosal surfaces in the head or neck. Because of its location, what you eat and drink can impact your risk of developing this type of cancer.
As you might imagine, two of the biggest risk factors for HNC are smoking and alcohol.
But in the same way that what you ingest can increase your risk, it can also reduce it.
That’s where coffee comes in.
Researchers looked at data from 14 studies that collected lifestyle information such as coffee consumption. The study included over 9,000 HNC cancer cases, and over 15,000 controls.
The people who drank three to four cups of caffeinated coffee daily had a 41 percent reduced risk of hypopharyngeal cancer (cancer in the bottom part of the throat), compared to non-coffee drinkers.
And those who drank more than four cups daily had the following:
- 17 percent reduced risk of HNC
- 22 percent reduced risk of oropharyngeal (cancer of the middle section of your throat)
- 30 percent reduced risk of oral cavity (cancer in the mouth or throat)
Overall, caffeinated coffee was associated with the greatest risk reduction. However, decaffeinated coffee drinkers had a 25 percent reduced risk of oral cavity cancer, compared to non-drinkers.
The takeaway here is simple. For better protection against head and neck cancer (plus heart disease, diabetes, Alzheimer’s, and more), make sure morning coffee is part of your daily routine.
P.S. “Forbidden” drink SLASHES colon cancer risk 32%.
View Sources
Nguyen, T., Koric, A., Chang, P. E., Barul, C., et. al., (2025). Coffee and tea consumption and the risk of head and neck cancer: An updated pooled analysis in the International Head and Neck Cancer Epidemiology Consortium. Cancer, 131(2), e35620.
